Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)
VS
UCLUCL
HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)

HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)

15/F, Building 17W, 17 Science Park West Avenue, Hong Kong Science Park, Sha Tin, New Territories, Hong Kong, HK

Last Update: 04/12/2025

View Profile
Between 750 and 799
https://www.hkcend.org/
750/1000Fair

Building on the pioneering work of HKUST’s State Key Laboratory of Molecular Neuroscience, Hong Kong Center for Neurodegenerative Diseases (HKCeND) is established as a research hub under the Health@InnoHK cluster for advanced research in neurodegenerative diseases, incl...

NAICS:5417
NAICS Definition:Scientific Research and Development Services
Employees:37
Subsidiaries:74
12-month incidents
0
Known data breaches
0
Attack type number
0
UCL

UCL

Gower Street, London, WC1E 6BT, London, Greater London, GB

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://www.ucl.ac.uk/
784/1000Fair

UCL (University College London) is London's leading multidisciplinary university, ranked 9th in the QS World University Rankings. Established in 1826 UCL opened up education in England for the first time to students of any race, class or religion and was also the first...

NAICS:5417
NAICS Definition:Scientific Research and Development Services
Employees:24,088
Subsidiaries:3
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)

HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
UCL

UCL

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Research Services Industry Avg (This Year)

No incidents recorded for HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) in 2026.

Incidents

Incidents vs Research Services Industry Avg (This Year)

No incidents recorded for UCL in 2026.

Incidents

Incident History - HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) (X = Date, Y = Severity)

HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - UCL (X = Date, Y = Severity)

UCL cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)

HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心)

Incidents
No explicit notable incidents reported.
UCL

UCL

Incidents
🔒 Incident : Ransomware
UCL1210311022

FAQ

Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has the best AI Cybersecurity Score ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has experienced more cyber incidents in the past ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has experienced more cyber incidents this year ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has experienced at least one ransomware attack ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has experienced at least one data breach ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has experienced at least one targeted cyberattack ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has experienced at least one vulnerability ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one holds the most compliance certifications ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one holds the fewest compliance certifications ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has the most subsidiaries ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) company and UCL company, which one has the largest number of employees ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) and UCL, which company holds both SOC 2 Type 1 certifications ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) and UCL, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) or UCL ?
Which company is PCI DSS compliant - HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) or UCL ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) and UCL, which company complies with HIPAA regulations for healthcare data ?
Between HKCeND - Hong Kong Center for Neurodegenerative Diseases (香港神經退行性疾病中心) and UCL, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-56078
SUMMARY

PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56077
SUMMARY

PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-56076
SUMMARY

PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-56075
SUMMARY

PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-56074
SUMMARY

PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.

PUBLISHED
Date2026-06-18
UPDATED
Date2026-06-18
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
CVSS4
Base Score: 6.8
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.8